<p>Pneumococcal serotype-specific opsonophagocytic activity geometric mean titer and 95% confidence interval among children aged 12–59 months before and after PHiD-CV (Groups A and B) or control vaccine (Group C). Group A N (range) by day: day 0 (0–110); day 30 (66–124); day 90 (104–121) Group B N (range) by day: day 0 (0–102); day 30 (60–119); day 210 (97–115) Group C N (range) by day: day 0 (3–109); day 30 (2–118); day 90 (2–118) Results for serotype 5 at day 0 not available because of insufficient specimen volume.</p
Association of pneumococcal nasopharyngeal carriage with the concentration and opsonophagocytic acti...
<p>Proportion of children aged 12–59 months with serotype-specific IgG ≥0.35 mcg/mL (A) and OPA≥8 (B...
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasiv...
<p>Pneumococcal serotype-specific IgG geometric mean concentration with 95% confidence interval amon...
<p>IgG geometric mean concentrations (GMCs) pre-booster, one week post-booster and one month post-bo...
<p>Serum antibody titers were assessed in 3-5-year-old children who had received PCV7 and PPV23 as i...
<p>Graphs present scatterplots of pneumococcal serotype-specific IgG antibody titers pre- and 1 mont...
Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumo...
INTRODUCTION: Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall i...
INTRODUCTION: Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall i...
<p>Serotypes 1, 5, and 7F are not included in the 7vPnC vaccine.</p>a<p>P<0.001 for fold increase at...
Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumo...
<p>Serotype-specific Antibody Forming Cells (AFCs) per 1x10<sup>6</sup> cultured PBMCs were measured...
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasiv...
<p>NA = Not applicable.</p><p>*Number of children.</p><p>**Number of serotypes (some children had mu...
Association of pneumococcal nasopharyngeal carriage with the concentration and opsonophagocytic acti...
<p>Proportion of children aged 12–59 months with serotype-specific IgG ≥0.35 mcg/mL (A) and OPA≥8 (B...
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasiv...
<p>Pneumococcal serotype-specific IgG geometric mean concentration with 95% confidence interval amon...
<p>IgG geometric mean concentrations (GMCs) pre-booster, one week post-booster and one month post-bo...
<p>Serum antibody titers were assessed in 3-5-year-old children who had received PCV7 and PPV23 as i...
<p>Graphs present scatterplots of pneumococcal serotype-specific IgG antibody titers pre- and 1 mont...
Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumo...
INTRODUCTION: Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall i...
INTRODUCTION: Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall i...
<p>Serotypes 1, 5, and 7F are not included in the 7vPnC vaccine.</p>a<p>P<0.001 for fold increase at...
Introduction of pneumococcal conjugate vaccines (PCVs) for infants decreased overall invasive pneumo...
<p>Serotype-specific Antibody Forming Cells (AFCs) per 1x10<sup>6</sup> cultured PBMCs were measured...
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasiv...
<p>NA = Not applicable.</p><p>*Number of children.</p><p>**Number of serotypes (some children had mu...
Association of pneumococcal nasopharyngeal carriage with the concentration and opsonophagocytic acti...
<p>Proportion of children aged 12–59 months with serotype-specific IgG ≥0.35 mcg/mL (A) and OPA≥8 (B...
Children in developing countries are frequently exposed to the pneumococcus, but few develop invasiv...